iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
21.46
-1.61 (-6.96%)
At close: Apr 1, 2025, 9:31 AM
21.39
-0.07 (-0.31%)
Pre-market: Apr 2, 2025, 4:09 AM EDT
IBRN Holdings List
As of Mar 31, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CPRX | Catalyst Pharmaceuticals, Inc. | 4.83% |
| 2 | ITCI | Intra-Cellular Therapies, Inc. | 4.40% |
| 3 | ARGX | argenx SE | 4.36% |
| 4 | NBIX | Neurocrine Biosciences, Inc. | 4.29% |
| 5 | PTCT | PTC Therapeutics, Inc. | 4.24% |
| 6 | ALKS | Alkermes plc | 4.18% |
| 7 | ACAD | ACADIA Pharmaceuticals Inc. | 4.14% |
| 8 | XENE | Xenon Pharmaceuticals Inc. | 4.03% |
| 9 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 3.97% |
| 10 | BIIB | Biogen Inc. | 3.96% |
| 11 | SRRK | Scholar Rock Holding Corporation | 3.91% |
| 12 | SUPN | Supernus Pharmaceuticals, Inc. | 3.86% |
| 13 | DNLI | Denali Therapeutics Inc. | 3.57% |
| 14 | BHVN | Biohaven Ltd. | 3.53% |
| 15 | EWTX | Edgewise Therapeutics, Inc. | 3.27% |
| 16 | IART | Integra LifeSciences Holdings Corporation | 3.22% |
| 17 | HLUNB.CO | H. LUNDBECK CLASS B | 3.00% |
| 18 | SRPT | Sarepta Therapeutics, Inc. | 2.69% |
| 19 | DYN | Dyne Therapeutics, Inc. | 1.94% |
| 20 | ASX: NEU | Neuren Pharmaceuticals Limited | 1.85% |
| 21 | AXGN | Axogen, Inc. | 1.71% |
| 22 | STO: BIOA.B | BioArctic AB (publ) | 1.59% |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 1.57% |
| 24 | AVXL | Anavex Life Sciences Corp. | 1.56% |
| 25 | AVDL | Avadel Pharmaceuticals plc | 1.53% |
| 26 | STO: DYVOX | Dynavox Group AB (publ) | 1.30% |
| 27 | TYO: 4592 | SanBio Company Limited | 1.28% |
| 28 | PRTA | Prothena Corporation plc | 1.16% |
| 29 | ZVRA | Zevra Therapeutics, Inc. | 0.87% |
| 30 | CBLL | CeriBell, Inc. | 0.86% |
| 31 | CAPR | Capricor Therapeutics, Inc. | 0.84% |
| 32 | DNTH | Dianthus Therapeutics, Inc. | 0.79% |
| 33 | EPA: MEDCL | MedinCell S.A. | 0.76% |
| 34 | RGNX | REGENXBIO Inc. | 0.71% |
| 35 | HKG: 2172 | MicroPort NeuroScientific Corporation | 0.67% |
| 36 | CLPT | ClearPoint Neuro, Inc. | 0.63% |
| 37 | NPCE | NeuroPace, Inc. | 0.62% |
| 38 | DRUG | Bright Minds Biosciences Inc. | 0.56% |
| 39 | VNDA | Vanda Pharmaceuticals Inc. | 0.55% |
| 40 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.50% |
| 41 | SLDB | Solid Biosciences Inc. | 0.49% |
| 42 | TSHA | Taysha Gene Therapies, Inc. | 0.48% |
| 43 | NVRO | Nevro Corp. | 0.46% |
| 44 | NGNE | Neurogene Inc. | 0.45% |
| 45 | TRDA | Entrada Therapeutics, Inc. | 0.44% |
| 46 | SWX: SANN | Santhera Pharmaceuticals Holding AG | 0.41% |
| 47 | ANNX | Annexon, Inc. | 0.41% |
| 48 | ABEO | Abeona Therapeutics Inc. | 0.40% |
| 49 | SWX: IDIA | Idorsia Ltd | 0.39% |
| 50 | RAPP | Rapport Therapeutics, Inc. | 0.39% |
As of Mar 31, 2025